ISSN:

Journal Home

Nanobiomedicine Q2 Unclaimed

SAGE Publications Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nanobiomedicine is a journal indexed in SJR in Biotechnology and Biomedical Engineering with an H index of 18. It is an CC BY-NC Journal with a Double blind peer review review system The scope of the journal is focused on nanomedicine, nanotechnology, biology, bioengineering, drug delivery, nanotoxicology. It has an SJR impact factor of 0,523 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,523.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biotechnology (Q2) Biomedical Engineering (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,523

SJR Impact factor

18

H Index

0

Total Docs (Last Year)

2

Total Docs (3 years)

0

Total Refs

6

Total Cites (3 years)

2

Citable Docs (3 years)

2

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biotechnology and Bioengineering Q2
World Journal of Microbiology and Biotechnology Q2
Journal of Industrial Microbiology and Biotechnology Q2
Journal of Basic Microbiology Q2
Biotechnology journal Q2

Compare this journals

Aims and Scope

Nanomedicine Nanotechnology Biology Bioengineering Drug delivery Nanotoxicology